SCHEMBL5261326

SCHEMBL5261326

CCCC(CC)NS(=O)(=O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.68
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
CA2 P00918 2/20 0.49
MMP2 P08253 7/20 0.45
MMP9 P14780 7/20 0.45
MMP8 P22894 4/20 0.45
MMP12 P39900 3/20 0.45
MMP14 P50281 3/20 0.45
CA14 Q9ULX7 1/20 0.45
CA7 P43166 1/20 0.44
ADAMTS4 O75173 2/20 0.44
PIN1 Q13526 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27821808 0.93 SMN1; SMN2 (0.72) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL25525586 0.90 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14281899 0.89 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL28034004 0.85 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL9577105 0.85 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL15341681 0.84 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6368625 0.83 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL19847358 0.81 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL13588576 0.81 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2228232 0.79 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836183-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS Galileo Pharmaceuticals, Inc. (US) 2007-09-26 EP disclosed
WO-2006065686-A2 SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS GALILEO PHARMACEUTICALS, INC. (US) 2006-06-22 WO disclosed